GlassScriptPhysician profile
Kevin M Kronner
NPI 1215932926
$2,074.19
in general payments reported to CMS, 2019-2025
30 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $33.36 · 2021: $108 · 2022: $647 · 2023: $419 · 2024: $306 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $320.40 | 2019-2025 | Xtandi |
| Pfizer INC. | $226.56 | 2022-2025 | |
| Janssen Biotech, INC. | $204.39 | 2019-2024 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $193.02 | 2022-2024 | Provenge |
| Abbvie INC. | $173.71 | 2019-2025 | |
| Rochester Medical Corporation | $133.60 | 2022 | |
| Urogen Pharma, INC. | $110.67 | 2020-2025 | |
| Allergan, INC. | $97.20 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $73.03 | 2022-2023 | Xiaflex |
| 180 Medical, INC. | $68.92 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $43.44 | 2019 | |
| Myovant Sciences INC. | $40.37 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $37.01 | 2025 | Optilume Urethral Drug Coated Balloon |
| Janssen Scientific Affairs, LLC | $36.64 | 2019 | |
| Sun Pharmaceutical Industries INC. | $35.00 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $31.72 | 2022 | |
| Amgen INC. | $28.32 | 2022 | |
| Ferring Pharmaceuticals INC. | $27.71 | 2019-2025 | Adstiladrin |
| Endo USA, INC. | $26.47 | 2025 | Xiaflex |
| Sumitomo Pharma America, INC. | $21.65 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $19.80 | 2023 | Lynparza, Keytruda |
| Teleflex LLC | $19.19 | 2025 | Barrigel |
| Antares Pharma, INC. | $17.19 | 2022 | |
| Boston Scientific Corporation | $16.86 | 2023 | Lithovue |
| Bayer Healthcare Pharmaceuticals INC. | $15.77 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $14.01 | 2023 | Bard Urinary Drainage Bag |
| Photocure INC | $13.15 | 2021 | |
| Coloplast Corp | $12.75 | 2023 | Altis |
| Myriad Genetic Laboratories, INC. | $11.82 | 2022 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kronner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.